Cargando…
Long Noncoding RNAs: Emerging Players in Medulloblastoma
Central Nervous System tumors are the leading cause of cancer-related death in children, and medulloblastoma has the highest incidence rate. The current therapies achieve a 5-year survival rate of 50–80%, but often inflict severe secondary effects demanding the urgent development of novel, effective...
Autores principales: | Laneve, Pietro, Rea, Jessica, Caffarelli, Elisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426782/ https://www.ncbi.nlm.nih.gov/pubmed/30923703 http://dx.doi.org/10.3389/fped.2019.00067 |
Ejemplares similares
-
Identification and Functional Characterization of Novel MYC-Regulated Long Noncoding RNAs in Group 3 Medulloblastoma
por: Rea, Jessica, et al.
Publicado: (2021) -
The Non-coding Side of Medulloblastoma
por: Laneve, Pietro, et al.
Publicado: (2020) -
The long noncoding RNA linc-NeD125 controls the expression of medulloblastoma driver genes by microRNA sponge activity
por: Laneve, Pietro, et al.
Publicado: (2017) -
RNA Deregulation in Amyotrophic Lateral Sclerosis: The Noncoding Perspective
por: Laneve, Pietro, et al.
Publicado: (2021) -
Long noncoding RNAs, emerging players in muscle differentiation and disease
por: Neguembor, Maria Victoria, et al.
Publicado: (2014)